Product
ZX003
1 clinical trial
2 indications
Indication
SchizophreniaIndication
Schizoaffective DisorderClinical trial
An Open-Label, Multiple Dose, Safety and Pharmacokinetic Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Patients With Chronic, Stable Schizophrenia or Schizoaffective DisorderStatus: Completed, Estimated PCD: 2015-09-01